Market research
ALSGD.PA SpineGuard SA
PA EUR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 0.8
- Dividend yield
- Not available
- Beta
- 0.63
Profile
Instrument facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- FR0011464452
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 0.8
- Dividend yield
- Not available
- Beta
- 0.63
About
About SpineGuard SA
SpineGuard SA provides designs, develops, and markets medical devices in the United States, Europe, Latin America, Asia Pacific, and the Middle East. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, PsiFGuard, and threaded PediGuard products. It also provides DSG Connect app that provides surgeons real time visualization of the audio feedback from the DSG Technology during pedicle drillings to ease the signal interpretation. The company's products are used in orthopedic robots and dental implantology. SpineGuard SA was incorporated in 2009 and is headquartered in Vincennes, France.
Research context
SpineGuard SA appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ALSGD.PA discussion.
5 years, 6 months ago
SpineGuard SA is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.4.
Based on the above factors, SpineGuard SA gets an overall score of 1/5.